MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Exploring the Therapeutic Target for Lewy Body Disease using gba1 Knock-out Medaka

    E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, H. Yamakado, R. Takahashi (kyoto, Japan)

    Objective: This study was performed to explore the therapeutic target for Lewy body disease. Background: Lewy body disease (LBD), including Parkinson's disease and diffuse Lewy…
  • 2024 International Congress

    Sphingomyelinase Activity in Patients with Sporadic Parkinson’s Disease

    A. Rekik, A. Mili, S. Naija, E. Jarrar, K. Jemai, A. Hassine, S. Ben Amor, J. Ben Abdallah (Sousse, Tunisia)

    Objective: To measure the sphingomyelinase (ASMase) activity in sporadic PD patients and matched healthy controls and identify any clinical or biological correlation with disease’s severity.To…
  • 2024 International Congress

    Machine Learning Model Comparison for Freezing of Gait Prediction in Advanced Parkinson’s Disease Patients

    J. Watts, A. Khojandi, R. Ramdhani (Knoxville, USA)

    Objective: This study compares the performance of machine learning classification models in predicting freezing of gait (FoG) from instrumented stand-and-walk trials in advanced Parkinson’s disease…
  • 2024 International Congress

    Use of Machine Learning for Identification of Parkinson’s Disease and Mild Cognitive Impairment through Neuroimaging and Biofluid Biomarkers: A Study from the PPMI Cohort

    A-G. Dennis, A. Strafella (Toronto, Canada)

    Objective: Since current diagnostic tests for Parkinson’s Disease (PD) and mild cognitive impairment (MCI) focus on individual biomarkers, misdiagnoses can be frequent. This research aims…
  • 2024 International Congress

    the Degeneration of Locus Coeruleus and its Enhanced Causal Relationship to Neural Circuit in Parkinson’s Tremor

    JY. Sun (Beijing, China)

    Objective: We aim to decode the neuroimaging features of LC in Parkinson's tremor. Background: Tremor is the primary symptom of Parkinson's disease (PD) and exhibits…
  • 2024 International Congress

    Effects of striatal dopamine depletion and altered brain metabolism on Parkinson’s disease

    HS. Yoo, PH. Lee, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To investigate the relationship between striatal dopamine depletion, altered brain metabolism, motor deficits, and cognitive dysfunction in Parkinson’s disease (PD) Background: PD shows degeneration…
  • 2024 International Congress

    Naturalistic walking in Parkinson’s disease: Prefrontal cortex activity measured with functional near-infrared spectroscopy (fNIRS)

    R. Kaplan, N. Mukadam, C. Aul, M. Rowe, N. Eklund, T. Nordahl, M. Yücel, T. Ellis, A. Cronin-Golomb (Boston, USA)

    Objective: In persons with Parkinson’s disease (PwPD), to observe brain activity in prefrontal cortex (PFC) using fNIRS during naturalistic walking that mimics everyday scenarios1, with…
  • 2024 International Congress

    Clinical Trends in Asleep and Awake DBS in North America vs Europe

    D. Pathadan, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, Y. Gordeyeva, J. Jimenez-Shahed, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, A. Tsai, J. Wong, L. Metmen (Bengaluru, India)

    Objective: To compare trends and perceptions regarding Asleep and Awake deep brain stimulation (DBS) in North America (NA) and Europe (EU). Background: DBS clinical practice…
  • 2024 International Congress

    Feasibility and added value of sensing feature in patients with chronic STN DBS for Parkinson’s disease

    A. Boogers, MB. Justich, M. Montiel, I. Alhashyan, S. Naghdlou, S. Kalia, A. Lozano, RP. Munhoz, A. Fasano (Toronto, Canada)

    Objective: To test the feasibility and usefulness of sensing features in patients undergoing replacement of their implantable pulse generator (IPG). Background: People with Parkinson’s disease…
  • 2024 International Congress

    Focused Ultrasound Thalamotomy for Tremor-Dominant Parkinson Disease – Ablation Volume and Dentatorubrothalamic Tract Overlap Does Not Predict Outcome

    J. Peters, J. Maamary, K. Kyle, I. Osborne, N. Olsen, L. Jones, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)

    Objective: To report the long-term outcomes in Tremor-Dominant Parkinson Disease (TDPD) after a unilateral Focused Ultrasound (uni-FUS) thalamotomy and explore factors that may predict the…
  • « Previous Page
  • 1
  • …
  • 176
  • 177
  • 178
  • 179
  • 180
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley